Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000
The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Mortality from coronary heart disease in the United States has decreased substantially in recent decades. We conducted a study to determine how much of this decrease could be explained by the use of medical and surgical treatments as opposed to changes in cardiovascular risk factors. METHODS: We applied a previously validated statistical model, IMPACT, to data on the use and effectiveness of specific cardiac treatments and on changes in risk factors between 1980 and 2000 among U.S. adults 25 to 84 years old. The difference between the observed and expected number of deaths from coronary heart disease in 2000 was distributed among the treatments and risk factors included in the analyses. RESULTS: From 1980 through 2000, the age-adjusted death rate for coronary heart disease fell from 542.9 to 266.8 deaths per 100,000 population among men and from 263.3 to 134.4 deaths per 100,000 population among women, resulting in 341,745 fewer deaths from coronary heart disease in 2000. Approximately 47% of this decrease was attributed to treatments, including secondary preventive therapies after myocardial infarction or revascularization (11%), initial treatments for acute myocardial infarction or unstable angina (10%), treatments for heart failure (9%), revascularization for chronic angina (5%), and other therapies (12%). Approximately 44% was attributed to changes in risk factors, including reductions in total cholesterol (24%), systolic blood pressure (20%), smoking prevalence (12%), and physical inactivity (5%), although these reductions were partially offset by increases in the body-mass index and the prevalence of diabetes, which accounted for an increased number of deaths (8% and 10%, respectively). CONCLUSIONS: Approximately half the decline in U.S. deaths from coronary heart disease from 1980 through 2000 may be attributable to reductions in major risk factors and approximately half to evidence-based medical therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Between 1950 and 1970 most of the decline in mortality rates from CVD was due to prevention (Goldman & Cook, 1984), whereas acute disease management and medical treatments accounted for about half of the decline between 1980 and 2000 (Ford et al., 2007).”
From Mortality and Morbidity Trends: Is There Compression of Morbidity? (2011) · cites this paper as Ford et al., 2007
In the citing paper
“Past studies show the effect of access to high-quality personal health care on both communicable and non-communicable diseases, highlighting the importance of prioritising personal health-care access and quality for all populations across the development spectrum.39–42”
In the citing paper
“Prevention works: .50% of the reductions seen in CHD mortality relate to changes in risk factors, and 40% to improved treatments.”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [29]
In the citing paper
“Another approach to understanding the changes in CVD mortality and incidence rates is by applying models such as the IMPACT mortality model.29 Based on information on changes in coronary risk factors and in treatment as obtained from the results of RCTs regarding the effectiveness of different treatment modalities, it estimates the expected influence on CHD mortality by age and gender.”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [29]
In the citing paper
“Beneficial reductions in major risk factors-in particular smoking, BP, and cholesterol-accounted for more than half of the decrease in CHD deaths, although they were counteracted by an increase in the prevalence of obesity and type 2 diabetes; 40% of the decline in CHD death rates is attributed to better treatments of acute myocardial infarction, heart failure, and other cardiac conditions.”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [29]
9 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
Prevalence of Overweight and Obesity Among US Children, Adolescents, and Adults, 1999-2002
Hedley, A. A. (2004) · JAMA · doi:10.1001/jama.291.23.2847 · Cited by 4,460
Writing Group Members, Thom, T., Haase, N., Rosamond, W., Howard, V. J., Rumsfeld, J., Manolio, T., Zheng, Z.-J., Flegal, K., O’Donnell, C., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.171600 · Cited by 3,451
Rosamond, W., Flegal, K., Friday, G., Furie, K., Go, A., Greenlund, K., Haase, N., Ho, M., Howard, V., Kissela, B., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.179918 · Cited by 3,277
Excess Deaths Associated With Underweight, Overweight, and Obesity
Flegal, K. M. (2005) · JAMA · doi:10.1001/jama.293.15.1861 · Cited by 2,824
Harris, M. I., Flegal, K. M., Cowie, C. C., Eberhardt, M. S., Goldstein, D. E., Little, R. R., Wiedmeyer, H.-M., & Byrd-Holt, D. D. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.518 · Cited by 2,703
A Potential Decline in Life Expectancy in the United States in the 21st Century
Olshansky, S. J., Passaro, D. J., Hershow, R. C., Layden, J., Carnes, B. A., Brody, J., Hayflick, L., Butler, R. N., Allison, D. B., & Ludwig, D. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmsr043743 · Cited by 2,612
Hajjar, I. (2003) · JAMA · doi:10.1001/jama.290.2.199 · Cited by 2,409
A Potential Decline in Life Expectancy in the United States in the 21st Century
Olshansky, S. J., Passaro, D. J., Hershow, R. C., Layden, J., Carnes, B. A., Brody, J., Hayflick, L., Butler, R. N., Allison, D. B., & Ludwig, D. S. (2005) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000167407.83915.e7 · Cited by 1,944
Research works printed but not linked: 3
- 2004, MMWR Morb Mortal Wkly Rep, 53, 82
- Ryan R, 2001, Health Stat Q, 12, 34
- Mokdad AH, 2003, MMWR Recomm Rep, 52, 1
Cited by
Items 501–600 of 1,006
Nonadherence, Clinical Inertia, or Therapeutic Inertia?
Allen, J. D., Curtiss, F. R., & Fairman, K. A. (2009) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2009.15.8.690 · Cited by 64
Secular Declines in the Association Between Obesity and Mortality in the United States
Mehta, N. K., & Chang, V. W. (2011) · Population and Development Review · doi:10.1111/j.1728-4457.2011.00429.x · Cited by 66
Green, L. A., Jones, S. M., Fetter, G. T., & Pugno, P. A. (2007) · Academic Medicine · doi:10.1097/acm.0b013e318159d070 · Cited by 65
Schram, A., Labonté, R., & Sanders, D. M. (2013) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2013.09.016 · Cited by 74
Trends in 10-Year Predicted Risk of Cardiovascular Disease in the United States, 1976 to 2004
López-Jiménez, F. A., Batsis, J. A., Roger, V. L., Brekke, L. N., Ting, H. H., & Somers, V. K. (2009) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.108.847202 · Cited by 67
Twenty-year trends in cardiovascular risk factors in India and influence of educational status
Gupta, R., Guptha, S., Gupta, V., Agrawal, A., Gaur, K., & DEEDWANIA, P. C. (2011) · European Journal of Preventive Cardiology · doi:10.1177/1741826711424567 · Cited by 70
Mastery is associated with cardiovascular disease mortality in men and women at apparently low risk.
Surtees, P. G., Wainwright, N. W. J., Luben, R., Wareham, N. J., Bingham, S. A., & Khaw, K.-T. (2010) · Health Psychology · doi:10.1037/a0019432 · Cited by 64
Kim, J. I., Sillah, A., Boucher, J. L., Sidebottom, A. C., & Knickelbine, T. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000058 · Cited by 69
Pandya, A., Gaziano, T. A., Weinstein, M. C., & Cutler, D. (2013) · Health Affairs · doi:10.1377/hlthaff.2013.0449 · Cited by 62
Cerebrovascular disease in 48 countries: secular trends in mortality 1950–2005
Mirzaei, M., Truswell, A. S., Arnett, K., Page, A., Taylor, R. J., & Leeder, S. (2011) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-300408 · Cited by 69
Kramer, M. R., Valderrama, A. L., & Casper, M. L. (2015) · American Journal of Epidemiology · doi:10.1093/aje/kwv050 · Cited by 69
dos Santos, J., Meira, K. C., Camacho, A. R., Salvador, P. T. C. D. O., Guimarães, R. M., Pierin, Â. M. G., Simões, T. C., & Freire, F. H. M. D. A. (2018) · Ciência & Saúde Coletiva · doi:10.1590/1413-81232018235.16092016 · Cited by 148
Current State of Cardiac Rehabilitation in Japan
Goto, Y. (2013) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2013.12.001 · Cited by 63
Norekvål, T. M., Fridlund, B., Rokne, B., Segadal, L., Wentzel‐Larsen, T., & Nordrehaug, J. E. (2010) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-8-140 · Cited by 65
Lubitz, C. C., Economopoulos, K. P., Sy, S., Johanson, C., Kunzel, H. E., Reincke, M., Gazelle, G. S., Weinstein, M. C., & Gaziano, T. A. (2015) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.115.002002 · Cited by 67
Hien, H. A., Tam, N. M., Tam, V., Derese, A., & Devroey, D. (2018) · International Journal of Hypertension · doi:10.1155/2018/6326984 · Cited by 63
Lin, W.-Y., Tsai, T.-H., Lee, M.-Y., Chou, W.-C., Chang, P.-C., Chou, C.-C., Wen, M.-S., Ho, M.-Y., Lee, W.-C., Hsieh, M.-J., et al. (2018) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2016.2620496 · Cited by 62
Efficacy of aerobic exercise on coronary heart disease risk factors
Kelley, G. A., & Kelley, K. S. (2008) · Preventive Cardiology · doi:10.1111/j.1751-7141.2008.08037.x · Cited by 62
Pre-Exposure Prophylaxis and the Promise of Combination Prevention Approaches
Buchbinder, S., & Liu, A. (2011) · AIDS and Behavior · doi:10.1007/s10461-011-9894-1 · Cited by 69
Camacho, X., Nedkoff, L., Wright, F., Nghiem, N., Buajitti, E., Goldacre, R., Rosella, L. C., Seminog, O. O., Tan, E. J., Hayes, A., et al. (2021) · The Lancet Public Health · doi:10.1016/s2468-2667(22)00006-8 · Cited by 75
Boshuizen, H. C., Lhachimi, S. K., van Baal, P. H. M., Hoogenveen, R. T., Smit, H. A., Mackenbach, J. P., & Nusselder, W. J. (2012) · Demography · doi:10.1007/s13524-012-0122-z · Cited by 70
Body mass index and incident coronary heart disease in women: a population-based prospective study
Collaborators, T. M. W. S., Canoy, D., Cairns, B. J., Balkwill, A., Wright, F. L., Green, J., REEVES, G. K., & Beral, V. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-87 · Cited by 75
Chen, Y., Li, L., Zhang, Q., Clarke, R., Chen, J., Yu, C., Bian, Z., Pan, X.-H., Peto, R., Tao, R., et al. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.12.065 · Cited by 65
Look AHEAD Research Group, Wing, R. R., Bray, G. A., Cassidy-Begay, M., Clark, J. M., Coday, M., Egan, C., Evans, M., Foreyt, J. P., Glasser, S., et al. (2022) · Diabetes Care · doi:10.2337/dc21-1805 · Cited by 61
Strand, B. H., Steingrímsdóttir, Ó. A., Grøholt, E., Ariansen, I., Graff‐Iversen, S., & Næss, Ø. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-1208 · Cited by 61
Population Aging and Hospitalization for Chronic Disease in Germany
Nowossadeck, E. (2012) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2012.0151 · Cited by 61
Helis, E., Augustincic, L., Steiner, S., Chen, L., Turton, P., & Fodor, J. G. (2011) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/1741826710389361 · Cited by 61
The Comparative Effectiveness of Heart Disease Prevention and Treatment Strategies
Kottke, T. E., Faith, D., Jordan, C. O., Pronk, N. P., Thomas, R. J., & Capewell, S. (2008) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2008.09.010 · Cited by 61
Self-citationPromoción de la salud cardiovascular global: estrategias, retos y oportunidades
Castellano, J. M., Narula, J., Castillo, J., & Fuster, V. (2014) · Revista Española de Cardiología · doi:10.1016/j.recesp.2014.01.024 · Cited by 93
Racial and geographic variation in coronary heart disease mortality trends
Gillum, R. F., Mehari, A., Curry, B. H., & Obisesan, T. O. (2012) · BMC Public Health · doi:10.1186/1471-2458-12-410 · Cited by 64
Redondo, A., Benach, J., Subirana, I., Martínez, J. M., Muñoz, M. Á., Masià, R., Ramos, R., Sala, J., Marrugat, J., & Elosúa, R. (2011) · Annals of Epidemiology · doi:10.1016/j.annepidem.2011.02.008 · Cited by 68
Patel, S. S., Guzmán, L. A., Lin, F., Pence, T. S., Reichman, T., John, B. V., Celi, F. S., Liptrap, E., Bhati, C. S., & Siddiqui, M. S. (2018) · Liver Transplantation · doi:10.1002/lt.25067 · Cited by 62
Women at Risk for Cardiovascular Disease Lack Knowledge of Heart Attack Symptoms
Flink, L. E., Sciacca, R. R., Bier, M. L., Rodriguez, J. K., & Giardina, E. V. (2013) · Clinical Cardiology · doi:10.1002/clc.22092 · Cited by 62
Cardiovascular disease trends in Nepal – An analysis of global burden of disease data 2017
Bhattarai, S., Aryal, A., Pyakurel, M., Bajracharya, S., Baral, P. P., Citrin, D., Cox, H., Dhimal, M., Fitzpatrick, A. L., Jha, A. K., et al. (2020) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2020.100602 · Cited by 73
Mortality and morbidity in ageing men: Biology, Lifestyle and Environment
Zhao, E., & Crimmins, E. M. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-022-09737-6 · Cited by 70
Ford, E. S., Roger, V. L., Dunlay, S. M., Go, A. S., & Rosamond, W. D. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.001097 · Cited by 56
Self-citationPublic health in New York City, 2002-2007: confronting epidemics of the modern era
Frieden, T. R., Bassett, M. T., Thorpe, L. E., & Farley, T. A. (2008) · International Journal of Epidemiology · doi:10.1093/ije/dyn108 · Cited by 60
Bending the Curve in Cardiovascular Disease Mortality: Bethesda + 40 and Beyond
Goff, D. C., Khan, S. S., Lloyd‐Jones, D. M., Arnett, D. K., Carnethon, M. R., Labarthe, D. R., Loop, M. S., Luepker, R. V., McConnell, M. V., Mensah, G. A., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.046501 · Cited by 66
Self-citationThe Economics of public health care reform in advanced and emerging economies
Coady, D., Clements, B. J., & Gupta, S. (2013) · Choice Reviews Online · doi:10.5860/choice.50-2774 · Cited by 60
Explaining the decline in coronary heart disease mortality in Portugal between 1995 and 2008
Pereira, M., Azevedo, A., Lunet, N., Carreira, H., O’Flaherty, M., Capewell, S., & Bennett, K. (2013) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.113.000264 · Cited by 59
Self-citationDolansky, M. A., Xu, F., Zullo, M., Shishehbor, M., Moore, S. M., & Rimm, A. A. (2010) · Journal of Cardiovascular Nursing · doi:10.1097/jcn.0b013e3181c9fbca · Cited by 59
Shah, N. P., Cainzos‐Achirica, M., Feldman, D. I., Blumenthal, R. S., Nasir, K., Miner, M. M., Billups, K. L., & Blaha, M. J. (2015) · The American Journal of Medicine · doi:10.1016/j.amjmed.2015.08.038 · Cited by 63
de Boer, S. P. M., Roos‐Hesselink, J. W., van Leeuwen, M. A. H., Lenzen, M. J., van Geuns, R., Regar, E. S., Mieghem, N. M. V., van Domburg, R., Zijlstra, F., Serruys, P. W. J. C., et al. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.07.091 · Cited by 62
Jelinek, M. V., Thompson, D. R., Ski, C. F., Bunker, S. J., & Vale, M. J. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.10.154 · Cited by 63
McManus, D. D., Piacentine, S. M., Lessard, D., Gore, J. M., Yarzebski, J., Spencer, F. A., & Goldberg, R. J. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.03.074 · Cited by 59
Changes in Cardiovascular Health in the United States, 2003–2011
Pilkerton, C. S., Singh, S. S., Bias, T. K., & Frisbee, S. J. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.114.001650 · Cited by 60
Induction of glutathione biosynthesis by glycine-based treatment mitigates atherosclerosis
Rom, O., Liu, Y., Finney, A. C., Ghrayeb, A., Zhao, Y., Shukha, Y., Wang, L., Rajanayake, K. K., Das, S. R., Rashdan, N. A., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102313 · Cited by 64
Ordúñez, P., Prieto-Lara, E., Gawryszewski, V. P., Hennis, A. J. M., & Cooper, R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141685 · Cited by 63
Citric Acid Cycle Intermediates in Cardioprotection
Czibik, G., Steeples, V., Yavari, A., & Ashrafian, H. (2014) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.114.000220 · Cited by 66
Cardiac Arrest: the Changing Incidence of Ventricular Fibrillation
Keller, S. P., & Halperin, H. R. (2015) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-015-0392-z · Cited by 58
Mitochondrial regulation of diabetic vascular disease: an emerging opportunity
Widlansky, M. E., & Hill, R. B. (2018) · Translational research · doi:10.1016/j.trsl.2018.07.015 · Cited by 66
Smolderen, K. G., Bell, A., Lei, Y., Cohen, E. A., Gabriel Steg, P., Bhatt, D. L., & Mahoney, E. M. (2010) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(10)70437-2 · Cited by 57
Effectiveness of nonpharmacological secondary prevention of coronary heart disease
Müller-Riemenschneider, F., Meinhard, C., Damm, K., Vauth, C., Bockelbrink, A., Greiner, W., & Willich, S. N. (2010) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e32833a1c95 · Cited by 57
Transitions From Heart Disease to Cancer as the Leading Cause of Death in US States, 1999–2016
Harding, M. C., Sloan, C., Merrill, R. M., Harding, T. M., Thacker, B. J., & Thacker, E. L. (2018) · Preventing Chronic Disease · doi:10.5888/pcd15.180151 · Cited by 60
Baumgartner, S., Bruckert, É., Gallo, A., & Plat, J. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.07.019 · Cited by 65
Epidemiology, Traditional and Novel Risk Factors in Coronary Artery Disease
Mack, M. C., & Gopal, A. (2014) · Cardiology Clinics · doi:10.1016/j.ccl.2014.04.003 · Cited by 63
Mapping body fat distribution: A key step towards the identification of the vulnerable patient?
Arsenault, B. J., Beaumont, E. P., Després, J.-P., & Larose, E. (2012) · Annals of Medicine · doi:10.3109/07853890.2011.605387 · Cited by 58
Weyland, P., Grant, W. B., & Howie‐Esquivel, J. (2014) · Nutrients · doi:10.3390/nu6093403 · Cited by 62
Identifying a Relationship Between Physical Frailty and Heart Failure Symptoms
Denfeld, Q. E., Winters‐Stone, K. M., Mudd, J. O., Hiatt, S. O., & Lee, C. S. (2017) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0000000000000408 · Cited by 57
Examining the Challenges of Recruiting Women Into a Cardiac Rehabilitation Clinical Trial
Beckie, T. M., Mendonca, M. A., Fletcher, G. F., Schocken, D. D., Evans, M. E., & Banks, S. M. (2009) · Journal of Cardiopulmonary Rehabilitation and Prevention · doi:10.1097/hcr.0b013e31819276cb · Cited by 57
Brown, T. M., Deng, L., Becker, D. J., Bittner, V., Levitan, E. B., Rosenson, R. S., Safford, M. M., & Muntner, P. (2015) · American Heart Journal · doi:10.1016/j.ahj.2015.04.027 · Cited by 60
The four health systems of the United Kingdom: how do they compare?
Bevan, G., Karanikolos, M., Exley, J., Nolte, E., Connolly, S., & Mays, N. (2014) · Cited by 56
Burden and Rates of Treatment and Control of Cardiovascular Disease Risk Factors in Obesity
Molenaar, E. A., Hwang, S., Vasan, R. S., Grobbee, D. E., Meigs, J. B., D’Agostino, R. B., Levy, D. A., & Fox, C. S. (2008) · Diabetes Care · doi:10.2337/dc07-2413 · Cited by 63
Potential survival gains in the treatment of myocardial infarction
Chew, D. P., Huynh, L. T., Liew, D., Astley, C. M., Soman, A., & Brieger, D. B. (2009) · Heart · doi:10.1136/hrt.2009.174276 · Cited by 58
Future of the Prevention and Treatment of Coronary Artery Disease
Steg, P. G., & Ducrocq, G. (2016) · Circulation Journal · doi:10.1253/circj.cj-16-0266 · Cited by 61
Renin–angiotensin system at the crossroad of hypertension and hypercholesterolemia
Borghi, C., Urso, R., & Cicero, A. F. G. (2016) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2016.07.013 · Cited by 60
Dehmer, S. P., Maciosek, M. V., LaFrance, A. B., & Flottemesch, T. J. (2017) · The Annals of Family Medicine · doi:10.1370/afm.2015 · Cited by 59
Trends in Obesity and Risk of Cardiovascular Disease
Lahey, R., & Khan, S. S. (2018) · Current Epidemiology Reports · doi:10.1007/s40471-018-0160-1 · Cited by 55
Cholesterol-Lowering Agents: Statins—For Everyone?
Hadjiphilippou, S., & Ray, K. K. (2019) · Circulation Research · doi:10.1161/circresaha.118.313245 · Cited by 49
Sanfélix‐Gimeno, G., Peiró, S., Ferreros, I., Vicente, R. P., Librero, J., Catalá-López, F., Ortiz, F., & Tortosa-Nácher, V. (2013) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2013.19.3.247 · Cited by 56
Risk Prediction for Early In-Hospital Mortality Following Heart Transplantation in the United States
Singh, T. P., Almond, C. S. D., Semigran, M. J., Piercey, G. E., & Gauvreau, K. (2012) · Circulation Heart Failure · doi:10.1161/circheartfailure.111.965996 · Cited by 59
Hoogendijk, E. O., Stolz, E., Voshaar, R. C. O., Deeg, D. J. H., Huisman, M. A., & Jeuring, H. W. (2021) · American Journal of Epidemiology · doi:10.1093/aje/kwab018 · Cited by 60
Yin, W., Lu, T., Chen, K.-C., Cheng, C.-F., Lee, J.-C., Liang, F., Huang, Y., & Yang, L. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.02.022 · Cited by 55
Cardiorespiratory fitness and nonfatalcardiovascular events: A population-based follow-up study
Khan, H., Jaffar, N., Rauramaa, R., Kurl, S., Savonen, K. P., & Laukkanen, J. A. (2016) · American Heart Journal · doi:10.1016/j.ahj.2016.10.019 · Cited by 59
Doadrio, A. L., Sánchez-Montero, J. M., Doadrio, J. C., Salinas, A. J., & Vallet‐Regí, M. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.11.002 · Cited by 57
Andrés, M., Bernal, J. A., Sivera, F., Quilis, N., Carmona, L., Vela, P., & Pascual, E. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-210357 · Cited by 59
Abubakar, S. M., Ukeyima, M. T., Spencer, J. P. E., & Lovegrove, J. A. (2019) · Nutrients · doi:10.3390/nu11020341 · Cited by 55
Preventive Cardiology as a Subspecialty of Cardiovascular Medicine
Shapiro, M. D., Maron, D. J., Morris, P. B., Kosiborod, M., Sandesara, P. B., Virani, S. S., Khera, A., Ballantyne, C. M., Baum, S. J., Sperling, L. S., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.08.1016 · Cited by 56
Parvar, S. L., Thiyagarajah, A., Nerlekar, N., King, P., & Nicholls, S. J. (2021) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2020.09.039 · Cited by 51
Is American Health Care Uniquely Inefficient?
Garber, A. M., & Skinner, J. (2008) · National Bureau of Economic Research · doi:10.3386/w14257 · Cited by 55
Christensen, D. M., Schjerning, A.-M., Smedegaard, L., Charlot, M. G., Ravn, P. B., Ruwald, A., Fosbøl, E. L., Køber, L., Torp-Pedersen, C. T., Schou, M., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac667 · Cited by 58
The Current State of Drug Discovery and a Potential Role for NMR Metabolomics
Powers, R. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401803b · Cited by 62
Boatman, P. D., Lauring, B. P., Schrader, T. O., Kasem, M., Johnson, B. R. G., Skinner, P. J., Jung, J., Xu, J., Cherrier, M. C., Webb, P. J., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm2010964 · Cited by 58
Kizer, J. R., Biggs, M. L., Ix, J. H., Mukamal, K. J., Zieman, S. J., de Boer, I. H., Mozaffarian, D., Barzilay, J. I., Strotmeyer, E. S., Luchsinger, J. A., et al. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq311 · Cited by 56
Kizer, J. R., Benkeser, D. C., Arnold, A. M., Djoussé, L., Zieman, S. J., Mukamal, K. J., Tracy, R. P., Mantzoros, C. S., Siscovick, D. S., Gottdiener, J. S., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2103 · Cited by 56
Trends in the Prevalence of Coronary Heart Disease in the U.S.
Yoon, S. S. (., Dillon, C. F., Illoh, K., & Carroll, M. (2016) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2016.02.023 · Cited by 53
Jouni, H., Askew, J. W., Crusan, D. J., Miller, T. D., & Gibbons, R. J. (2017) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.116.005628 · Cited by 54
Templin, C., Lscher, T. F., & Landmesser, U. (2011) · The International Journal of Developmental Biology · doi:10.1387/ijdb.103219ct · Cited by 56
Becker, R. C., Scheiman, J. M., Dauerman, H. L., Spencer, F. A., Rao, S. V., Sabatine, M. S., Johnson, D. A., Chan, F., Abraham, N. S., & Quigley, E. M. M. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.09.012 · Cited by 55
Translation of hypertension treatment guidelines into practice: a review of implementation
Handler, J., & Lackland, D. T. (2011) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2011.03.002 · Cited by 55
Kim, L. K., Feldman, D. N., Swaminathan, R. V., Minutello, R. M., Chanin, J. M., Yang, D. C.-S., Lee, M. K., Charitakis, K., Shah, A. M., Kaple, R., et al. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.07.013 · Cited by 53
Vaccarezza, M., Papa, V., Milani, D., Gonelli, A., Secchiero, P., Zauli, G., Gemmati, D., & Tisato, V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041477 · Cited by 58
Will screening individuals at high risk of cardiovascular events deliver large benefits? No
Capewell, S. (2008) · BMJ · doi:10.1136/bmj.a1395 · Cited by 52
Self-citationWhat explains declining coronary mortality? Lessons and warnings
Capewell, S., & O’Flaherty, M. (2008) · Heart · doi:10.1136/hrt.2008.149930 · Cited by 53
Self-citationPredictive risk algorithms in a population setting: an overview
Manuel, D. G., Rosella, L. C., Hennessy, D. A., Sanmartin, C., & Wilson, K. R. (2012) · Journal of Epidemiology & Community Health · doi:10.1136/jech-2012-200971 · Cited by 60
Bench-to-bedside review: The evaluation of complex interventions in critical care
Delaney, A. P., Angus, D. C., Bellomo, R., Cameron, P. A., Cooper, D. J., Finfer, S. R., Harrison, D. A., Huang, D. T., Myburgh, J., Peake, S., et al. (2008) · Critical Care · doi:10.1186/cc6849 · Cited by 60
Urbinati, S., Olivari, Z., Gonzini, L., Savonitto, S., Farina, R., Pinto, M. D., Valbusa, A., Fantini, G., Mazzoni, A., Maggioni, A. P., et al. (2014) · European Journal of Preventive Cardiology · doi:10.1177/2047487314561876 · Cited by 59
Sándor, B., Nagy, A., Toth, A., Rábai, M., Mezey, B., Csathó, Á., Czuriga, I., Tóth, K., & Szabados, E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110751 · Cited by 52
Has guideline development gone astray? No
Gibbons, R. J., Antman, E. M., & Smith, S. C. (2010) · BMJ · doi:10.1136/bmj.c343 · Cited by 54
Coronary Heart Disease in Women: Update 2008
WENGER, N. K., Shaw, L. J., & Vaccarino, V. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100447 · Cited by 54
Metadata
- Authors
- Ford, E. S., Ajani, U. A., Croft, J. B., Critchley, J. A., Labarthe, D. R., Kottke, T. E., Giles, W. H., & Capewell, S.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Newcastle University (GB)
- HealthPartners (US)
- University of Liverpool (GB)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2007-06-07
- Volume
- 356
- Issue
- 23
- Pages
- 2388-2398
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2150278133
- Cited by
- 2,757
- References
- 44
- Citations by year
- 2026: 56 · 2025: 66 · 2024: 60 · 2023: 82 · 2022: 100 · 2021: 101 · 2020: 114 · 2019: 129 · 2018: 129 · 2017: 153 · 2016: 163 · 2015: 209 · 2014: 173 · 2013: 198 · 2012: 252
- FWCI
- 127.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Healthcare Systems and Public Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Keywords
- coronary heart disease mortality, mortality decline, cardiovascular risk factors, IMPACT model, secondary prevention after myocardial infarction, revascularization, acute myocardial infarction treatment, unstable angina, heart failure treatment, cholesterol lowering, blood pressure reduction, smoking, physical inactivity, body mass index, diabetes mellitus, sex differences in mortality
- MeSH terms
- Adult, Aged, Aged, 80 and over, Coronary Disease, Female, Humans, Male, Middle Aged, Mortality, Myocardial Infarction, Myocardial Revascularization, Risk Factors, United States
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.